JPRN-UMIN000034416
Completed
未知
Effect of topical antiglaucoma medications on prevention for intraocular pressure elevation after cataract surgery in eyes with glaucoma : a randomized clinical comparative study. - Topical antiglaucoma agents against IOP elevation after cataract surgery
ConditionsOpen-angle glaucoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Open-angle glaucoma
- Sponsor
- Hayashi Eye Hospital
- Enrollment
- 165
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria were 1\) eyes with any ocular pathology other than cataract and glaucoma; 2\) eyes scheduled for planned extracapsular or intracapsular cataract extraction; 3\) history of previous ocular surgery or inflammation; 4\) patients with contraindication for administration of prostaglandin F2A analogues, B\-blockers, topical carbonic anhydrase inhibitor; 5\) patient refusal; 6\) any anticipated difficulties with examination or follow\-up; and 7\) patients who were included in another study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of antiglaucoma medications on choroidal thicknessIRCT20180203038597N1Mashhad University of Medical Sciences60
Recruiting
Not Applicable
The Effect of conventional antiglaucoma medications; such as Timolol, Brimonidin, Latanoprost and Dorzolamide Eye Drops on Prepapillary and Optic Nerve Head CirculatioIRCT20190405043168N1Mashhad University of Medical Sciences80
Completed
Not Applicable
Investigation of the influence of anti-glaucoma eyedrops on corneal stroma and corneal shapeglaucomaJPRN-UMIN000030262Inouye Eye Hospital300
Completed
Not Applicable
Investigation of the influence of anti-glaucoma eyedrops on the ocular surfaceglaucomaJPRN-UMIN000030246Inouye Eye Hospital300
Active, not recruiting
Not Applicable
Effects of common topical glaucoma therapy on optic nerve head blood flow autoregulation during increased arterial blood pressure and artificially elevated intraocular pressure in healthy humansonly healthy volunteers are includedEUCTR2005-005895-34-ATDepartment of Clinical Pharmacology, Medical University of Vienna54